Alcohol Use Disorder Treatment Market - 2024-2031

October 2024 | 56 pages | ID: A6CB665507CFEN
DataM Intelligence

Abstracts

The Alcohol Use Disorder Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.

A Alcohol Use Disorder Treatment Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.

By Disorder Type

• Alcohol Abuse*
• Alcohol Dependence
• Alcohol Addiction
• Alcoholism

By End-user

• Medication*
• Opioid Receptor Antagonist
• Naltrexone
• Glutamate Agonist
• Acamprosate
• Alcohol Antagonist Drug
• Disulfiram
• Other Medications (Gabapentin and Topiramate)
• Multidisciplinary Treatment
• Others

Regional Analysis for Alcohol Use Disorder Treatment Market:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

This Report Covers:

• Go-to-market Strategy.
• Neutral perspective on the market performance.
• Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
• Customized regional/country reports as per request and country level analysis.
• Potential & niche segments and regions exhibiting promising growth covered.
• Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Research Process:

Both primary and secondary data sources have been used in the global Alcohol Use Disorder Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Disorder Type
3.2. Snippet by Treatment Type
3.3. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. The Increasing Prevalence of Alcohol Use Disorder
    4.1.1.2. XX
  4.1.2. Restraints
    4.1.2.1. Limited Access to Treatment
    4.1.2.2. XX
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID
  6.1.2. Scenario During COVID
  6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY DISORDER TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  7.1.2. Market Attractiveness Index, By Disorder Type
7.2. Alcohol Abuse*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Alcohol Dependence
7.4. Alcohol Addiction
7.5. Alcoholism

8. BY END-USER

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
  8.1.2. Market Attractiveness Index, By End-user
8.2. Medication*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  8.2.3. Opioid Receptor Antagonist
    8.2.3.1. Naltrexone
  8.2.4. Glutamate Agonist
    8.2.4.1. Acamprosate
  8.2.5. Alcohol Antagonist Drug
    8.2.5.1. Disulfiram
  8.2.6. Other Medications (Gabapentin and Topiramate)
8.3. Multidisciplinary Treatment
8.4. Others

9. BY REGION

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  9.1.2. Market Attractiveness Index, By Region
9.2. North America
  9.2.1. Introduction
  9.2.2. Key Region-Specific Dynamics
  9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.2.5.1. U.S.
    9.2.5.2. Canada
    9.2.5.3. Mexico
9.3. Europe
  9.3.1. Introduction
  9.3.2. Key Region-Specific Dynamics
  9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.3.5.1. Germany
    9.3.5.2. UK
    9.3.5.3. France
    9.3.5.4. Italy
    9.3.5.5. Spain
    9.3.5.6. Rest of Europe
9.4. South America
  9.4.1. Introduction
  9.4.2. Key Region-Specific Dynamics
  9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.4.5.1. Brazil
    9.4.5.2. Argentina
    9.4.5.3. Rest of South America
9.5. Asia-Pacific
  9.5.1. Introduction
  9.5.2. Key Region-Specific Dynamics
  9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    9.5.5.1. China
    9.5.5.2. India
    9.5.5.3. Japan
    9.5.5.4. Australia
    9.5.5.5. Rest of Asia-Pacific
9.6. Middle East and Africa
  9.6.1. Introduction
  9.6.2. Key Region-Specific Dynamics
  9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disorder Type
  9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type

10. COMPETITIVE LANDSCAPE

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. COMPANY PROFILES

11.1. Sobrera Pharma*
11.2. Company Overview
11.3. Product Portfolio and Description
11.4. Financial Overview
11.5. Key Developments
11.1. Recipharm
11.2. Alkermes, Inc.,
11.3. ADial Pharmaceuticals, Inc.
11.4. Addex Therapeutics
11.5. Kinnov Therapeutics
11.6. Opiant Pharmaceuticals Inc.
11.7. Omeros Corporation
11.8. Pfizer
11.9. Lundbeck (LIST NOT EXHAUSTIVE)

12. APPENDIX

12.1. About Us and Services
12.2. Contact Us